Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong-Xin Wang, MD, PhD
Peking University First Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Hospital of the Ministry of Health
Beijing, Beijing Municipality, China
- Beijing Youan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
- Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Peking University First Hospital
Beijing, Beijing Municipality, China
- Tongji Hospital, Tongji Medical College of Hust
Wuhan, Hubei, China
- Wuhan Puai Hospital
Wuhan, Hubei, China
- Suzhou Municipal Hospital
Suzhou, Jiangsu, China
- Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
- Cancer Hospital of the University of Chinese Academy of Sciences (zhejiang Cancer Hospital)
Hangzhou, Zhejiang, China
- the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 May 2021
- Primary completion
- 31 Dec 2022
- Completion
- 22 Apr 2023
- Last update posted
- 3 Jan 2024
- Registered enrollment
- 552
- Registry id
- NCT04861337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.